Podcast description: centenarian genetics, metformin and biological-age tests discussed
Thumbnail from YouTube. Playing loads the YouTube player.
History & recommendationsOff
Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.
Open saved items & history →At a glance
Automatic summary · not editorially reviewedThe description announces a podcast with Dr. Nir Barzilai on protective genes in people over 100, drugs such as metformin, GLP-1 and SGLT2 inhibitors, peptides, biological-age tests and the goal of staying healthy to the end of life. It reports no study results. [1]
The description says Barzilai studies protective genes delaying aging and age-related diseases in people over 100. [1]
The description lists metformin, GLP-1 and SGLT2 inhibitors as drugs whose longevity potential is discussed. [1]
The description states the main goal is not only longer life but staying healthy to the end. [1]
Centenarian genes and limits of lifestyle
According to the description, Barzilai is a professor of medicine and genetics and director of a geroscience institute, and studies protective genes that delay aging and age-related diseases in people over 100. The description says his research shows that healthy, long life cannot be explained by nutrition, exercise and supplements alone, and asks how some people pass 100 despite not following healthy-living rules. These are attributed to the description and creator; no data are given. [1]
Drugs, peptides and biological-age tests
The description lists topics for the episode: how growth hormone and IGF-1 effects change with age; the longevity potential of drugs such as metformin, GLP-1 and SGLT2 inhibitors; risks of the peptides MOTS-c and Humanin; unnecessary supplement use; the future of biological-age tests; and the evidence levels for hyperbaric oxygen and stem-cell treatments. It also names Barzilai as an originator of the TAME study on metformin and aging. The description gives no findings, effect sizes or safety conclusions for any of these. [1]
Stated aim: healthspan, not only longer life
The description says the discussion covers why people should target the biology of aging rather than treating diseases, and that the main goal is not only living longer but staying healthy until the end of life. It also states that the information is for information only and does not aim to guide diagnosis or treatment. These are the creator's framing statements, not results of a study. [1]
Context & limits
Only the video description was available; the video and transcript were not reviewed. The description announces topics and gives no study design, sample, results or effect sizes, so no efficacy or safety conclusions can be drawn.
Based on the creator’s description; the full video and transcript were not analyzed.
Quoted passages in the original language
koruyucu genleri araştırıyor
metformin, GLP-1 ve SGLT2 inhibitörleri gibi ilaçların
hayatın sonuna kadar sağlıklı kalabilmek
About this video
Creator description · original textText language: Turkish
Ayık Kafa · 2 min · Source published: 2026-10-20
Added to Harbor: 10/23/2026
Original on YouTube ↗Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.